变态反应和特异性免疫治疗的数学模型:Th1-Th2-Treg相互作用
Mathematical Modelling of Allergy and Specific Immunotherapy: Th1-Th2-Treg Interactions
摘要:
调节性T细胞(Treg)最近被确定为在过敏和过敏原特异性免疫治疗中发挥核心作用。我们已经扩展了我们以前的数学模型描述的非线性动力学的Th 1-Th 2调节包括Treg细胞和它们的主要细胞因子。我们假设免疫治疗主要作用于T细胞水平,并且决定性过程可以被视为一种动力学现象。该模型由描述不同T细胞亚群的增殖和相互抑制的非线性微分方程组成。旧版本的模型是基于Th 1-Th 2范式,并成功地描述了“Th 1-Th 2开关”,这被认为是特异性免疫治疗期间的决定性事件。然而,近年来,Th 1-Th 2范式受到质疑,因此,我们研究了一种修改后的模型,以解释调节性T细胞类型的影响。我们研究了扩展模型的数值模拟和分析方法。由于修改后的模型更加复杂,我们不得不开发新的方法来描绘其特征。频闪映射的不动点的稳定流形的概念变得特别重要。我们发现,当包括调节性T细胞时,我们的模型可以更准确地描述过敏原特异性免疫治疗中的事件。我们的研究结果表明,免疫治疗的决定性作用,Treg细胞增殖的增加和Th 2细胞的抑制,关键取决于在维持期开始前给予高剂量注射。因此,可以通过优化这一治疗步骤来改进经验方案。
英文摘要:
Regulatory T cells (Treg) have recently been identified as playing a central role in allergy and during allergen-specific immunotherapy. We have extended our previous mathematical model describing the nonlinear dynamics of Th1-Th2 regulation by including Treg cells and their major cytokines. We hypothesize that immunotherapy mainly acts on the T cell level and that the decisive process can be regarded as a dynamical phenomenon. The model consists of nonlinear differential equations which describe the proliferation and mutual suppression of different T cell subsets. The old version of the model was based upon the Th1-Th2 paradigm and is successful in describing the "Th1-Th2 switch" which was considered the decisive event during specific immunotherapy. In recent years, however, the Th1-Th2 paradigm has been questioned and therefore, we have investigated a modified model in order to account for the influence of a regulatory T cell type. We examined the extended model by means of numerical simulations and analytical methods. As the modified model is more complex, we had to develop new methods to portray its characteristics. The concept of stable manifolds of fixed points of a stroboscobic map turned out to be especially important. We found that when including regulatory T cells, our model can describe the events in allergen-specific immunotherapy more accurately. Our results suggest that the decisive effect of immunotherapy, the increased proliferation of Treg and suppression of Th2 cells, crucially depends on the administration of high dose injections right before the maintenance phase sets in. Empirical protocols could therefore be improved by optimizing this step of therapy.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。